Skip to main content
OpenTrials

Clinical trial condition

Borderline Personality Disorder

Explore clinical trials studying Borderline Personality Disorder. Study availability and eligibility vary by location and protocol.

164 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Borderline Personality Disorder trial results

Completed

Olanzapine in Patients With Borderline Personality Disorder

NCT00091650

Conditions
Borderline Personality Disorder, Mental Disorders, Personality Disorders
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Atlanta, Georgia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Marietta, Georgia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Minneapolis, Minnesota, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Las Vegas, Nevada, United States
View all 39 locations
View Trial Details
Completed

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

NCT00088036

Conditions
Borderline Personality Disorder, Mental Disorders, Personality Disorders
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician National City, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician New Haven, Connecticut, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Indianapolis, Indiana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Jackson, Mississippi, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder

NCT07001475

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +4 more
Locations
  • Charité Research Organisation GmbH Berlin, Germany
  • Universitätsklinikum Bonn AöR Bonn, Germany
  • Universitätsklinikum Frankfurt Frankfurt am Main, Germany
  • Martin-Luther-Universität Halle-Wittenberg Halle, Germany
View Trial Details
Active, Not Recruiting

PILOT Phase: BPD Study

NCT07223619

Conditions
Borderline Personality Disorder, Mental Disorders, Personality Disorders
Locations
  • Semel Institute/ UCLA TMS Los Angeles, California, United States
View Trial Details

Related conditions